Autopsy report · NCT02403895
AZD2014 and Weekly Paclitaxel in Squamous NSCLC
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 8 months before it stopped.
- 11 participants enrolled.
- Results were posted on the registry 1 year 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Squamous Non Small Cell Lung Cancer
- Interventions
- Open-label AZD2014; paclitaxel
- Participants
- 11
- Sites
- 7
- Countries
- Germany, Spain, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.